<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000613208"><TermName>Fludara</TermName><TermPronunciation>(floo-DAR-uh)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat B-cell chronic lymphocytic leukemia (CLL) that has not responded to treatment with other anticancer drugs or that has gotten worse. It is also being studied in the treatment of other types of cancer. Fludara blocks cells from making DNA and may kill cancer cells. It is a type of purine antagonist and a type of ribonucleotide reductase inhibitor. Also called fludarabine phosphate.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000720789" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Fludara&quot;" language="en" id="_3"/><MediaLink ref="CDR0000720788" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Fludara&quot;" language="es" id="_4"/><SpanishTermName>Fludara</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar la leucemia linfocítica crónica (LLC) de células B que no ha respondido al tratamiento con otros medicamentos contra el cáncer o que ha empeorado. Asimismo, está en estudio para el tratamiento de otros tipos de cáncer. Fludara impide que las células produzcan ADN y puede destruir las células cancerosas. Es un tipo de antagonista de la purina y un tipo de inhibidor de la ribonucleótido reductasa. También se llama fosfato de fludarabina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2008-08-25</DateFirstPublished><RelatedInformation><RelatedDrugSummaryRef href="CDR0000597019">Fludarabine Phosphate</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
